|
Jul 31
|
Tariff deadline, jobs report, Exxon earnings: What to Watch
|
|
Jul 31
|
Moderna plans to slash 10% of workforce as COVID shot sales slow
|
|
Jul 31
|
Moderna to Report Earnings Amid Shrinking Cash Balance. Investors Want to See If It Can Stop the Bleeding.
|
|
Jul 31
|
Sector Update: Health Care Stocks Fall Late Afternoon
|
|
Jul 31
|
Health Care Roundup: Market Talk
|
|
Jul 31
|
Nvidia, eBay, Moderna: Trending Tickers
|
|
Jul 31
|
Moderna to lay off 10% of workforce in ‘difficult but necessary step’
|
|
Jul 31
|
Moderna Cuts 10% of Its Staff as Cash Hoard Dwindles
|
|
Jul 31
|
Moderna Earnings: What To Look For From MRNA
|
|
Jul 30
|
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
|
|
Jul 29
|
1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year
|
|
Jul 29
|
Curious about Moderna (MRNA) Q2 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Jul 29
|
dbt Labs Signs Strategic Collaboration Agreement with AWS
|
|
Jul 29
|
Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?
|
|
Jul 28
|
Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.
|
|
Jul 28
|
Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline
|
|
Jul 28
|
Moderna Announces Data to be Presented at ESMO Congress 2025
|
|
Jul 25
|
Biotech Is Booming, and This Undervalued REIT Stands to Gain
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|
|
Jul 25
|
Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|